Home/Centrexion Therapeutics/James N. Campbell, M.D.

JN

James N. Campbell, M.D.

President, Chief Scientific Officer

Centrexion Therapeutics

Therapeutic Areas

Chronic Pain Immunology Autoimmune Diseases

Centrexion Therapeutics Pipeline

Drug	Indication	Phase
Pain Pipeline	Chronic Pain	Clinical Stage
Immunology Pipeline	Autoimmune/Inflammatory Diseases	Exploratory/Pre-clinical

Leadership Team at Centrexion Therapeutics

Jeffrey B. Kindler

Chief Executive Officer

Charles Oh, M.D.

Chief Medical Officer

Sol Barer, Ph.D.

Chairman of the Board

View full Centrexion Therapeutics profile